Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 18, 2009 - Issue 3
Submit an article Journal homepage
87
Views
11
CrossRef citations to date
0
Altmetric
Meeting Highlights

Highlights of regional meeting of Italian Southern Oncological Group (GOIM): focus on hepatocellular carcinoma: biological and clinical background, therapeutic guide-lines and perspectives

7 November 2008, Naples, Italy

Raffaele Addeo “S. Giovanni di Dio” Hospital, U.O.C. Oncologia, ASL Napoli3 Frattaminore, Naples, Italy
,
Michele Caraglia Second University of Naples, Department of Biochemistry and Biophysics, Via Costantinopoli, 16 80138, Naples, Italy +39 0815665871 (office),+39 0815665874 (lab); +39 0815665863; [email protected]
&
Salvatore Del Prete “S. Giovanni di Dio” Hospital, U.O.C. Oncologia, ASL Napoli3 Frattaminore, Naples, Italy
Pages 373-378 | Published online: 09 May 2009

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Zheng Wang, Jie Hu, Shuang-Jian Qiu, Xiao-Wu Huang, Zhi Dai, Chang-Jun Tan, Jian Zhou & Jia Fan. (2011) An investigation of the effect of sorafenib on tumour growth and recurrence after liver cancer resection in nude mice independent of phosphorylated extracellular signal-regulated kinase levels. Expert Opinion on Investigational Drugs 20:8, pages 1039-1045.
Read now
Liliana Montella, Raffaele Addeo, Michele Caraglia & Salvatore Del Prete. (2010) Latest developments in targeted therapy for hepatocellular carcinoma. Expert Review of Anticancer Therapy 10:10, pages 1635-1646.
Read now

Articles from other publishers (9)

Ningyuan WenYulong CaiFuyu LiHui YeWei TangPeipei SongNansheng Cheng. (2022) The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines: 2022 update. BioScience Trends 16:1, pages 20-30.
Crossref
Guorun Fan, Yaqin Tu, Cai Chen, Haiying Sun, Chidan Wan & Xiong Cai. (2018) DNA methylation biomarkers for hepatocellular carcinoma. Cancer Cell International 18:1.
Crossref
Peipei Song, Yulong Cai, Haowen Tang, Chuan Li & Jiwei Huang. (2017) The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines from 2001 to 2017. BioScience Trends 11:4, pages 389-398.
Crossref
Peipei Song, Wei Tang, Kiyoshi Hasegawa & Norihiro Kokudo. (2014) Systematic evidence-based clinical practice guidelines are ushering in a new stage of standardized management of hepatocellular carcinoma in Japan. Drug Discoveries & Therapeutics 8:2, pages 64-70.
Crossref
Irene CruiteAn TangClaude B. Sirlin. (2013) Imaging-Based Diagnostic Systems for Hepatocellular Carcinoma. American Journal of Roentgenology 201:1, pages 41-55.
Crossref
Liliana Montella, Raffaele Addeo, Gregorio Cennamo, Bruno Vincenzi, Rita Palmieri, Pasquale Sperlongano, Rossella Sperlongano, Patrizia Iodice, Paola Russo & Salvatore Del Prete. (2013) Sorafenib in Elderly Patients with Advanced Hepatocellular Carcinoma: A Case Series. Oncology 84:5, pages 265-272.
Crossref
Monica Marra, Ignazio M Sordelli, Angela Lombardi, Monica Lamberti, Luciano Tarantino, Aldo Giudice, Paola Stiuso, Alberto Abbruzzese, Rossella Sperlongano, Marina Accardo, Massimo Agresti, Michele Caraglia & Pasquale Sperlongano. (2011) Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview. Journal of Translational Medicine 9:1.
Crossref
Salvatore Del Prete, Liliana Montella, Michele Caraglia, Luigi Maiorino, Gregorio Cennamo, Vincenzo Montesarchio, Guido Piai, Antonio Febbraro, Luciano Tarantino, Elena Capasso, Giovannella Palmieri, Rosario Guarrasi, Maddalena Bianco, Rosanna Mamone, Clementina Savastano, Agata Pisano, Bruno Vincenzi, Antonietta Sabia, Alberto D’Agostino, Vincenzo Faiola & Raffaele Addeo. (2009) Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study. Cancer Chemotherapy and Pharmacology 66:5, pages 837-844.
Crossref
Bruno Vincenzi, Daniele Santini, Antonio Russo, Raffaele Addeo, Francesco Giuliani, Liliana Montella, Sergio Rizzo, Olga Venditti, Anna Maria Frezza, Michele Caraglia, Giuseppe Colucci, Salvatore Del Prete & Giuseppe Tonini. (2010) Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib. The Oncologist 15:1, pages 85-92.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.